Armistice Capital’s Deciphera Pharmaceuticals, Inc. Common Stock DCPH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-5,900,000
| Closed | -$92.8M | – | 402 |
|
|
2024
Q1 | $92.8M | Buy |
5,900,000
+700,000
| +13% | +$11M | 1.23% | 7 |
|
|
2023
Q4 | $83.9M | Buy |
5,200,000
+588,000
| +13% | +$9.48M | 1.15% | 6 |
|
|
2023
Q3 | $58.7M | Buy |
4,612,000
+52,000
| +1% | +$661K | 0.9% | 17 |
|
|
2023
Q2 | $64.2M | Buy |
4,560,000
+460,000
| +11% | +$6.48M | 0.93% | 19 |
|
|
2023
Q1 | $63.3M | Sell |
4,100,000
-1,072,000
| -21% | -$16.6M | 0.91% | 24 |
|
|
2022
Q4 | $84.8M | Buy |
5,172,000
+404,000
| +8% | +$6.62M | 1.48% | 13 |
|
|
2022
Q3 | $88.2M | Sell |
4,768,000
-632,000
| -12% | -$11.7M | 1.53% | 12 |
|
|
2022
Q2 | $71K | Sell |
5,400,000
-436,000
| -7% | -$5.73K | 1.24% | 20 |
|
|
2022
Q1 | $54.1M | Buy |
5,836,000
+2,405,846
| +70% | +$22.3M | 1.05% | 27 |
|
|
2021
Q4 | $33.5M | Buy |
3,430,154
+2,752,154
| +406% | +$26.9M | 0.55% | 42 |
|
|
2021
Q3 | $23M | Buy |
678,000
+206,000
| +44% | +$7M | 0.39% | 63 |
|
|
2021
Q2 | $17.3M | Buy |
+472,000
| New | +$17.3M | 0.31% | 71 |
|